机构：[1]Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China[2]The First Affiliated Hospital of Xinjiang Medical University, Urumqi, China[3]Yulin First People's Hospital, Yulin, China[4]Guilin People's Hospital, Guilin, China[5]The Third Affiliated Hospital of Chongqing Medical University, Chongqing, China[6]OrigiMed, Shanghai, China[7]State Key Laboratory of Translational Oncology, Chinese University of Hong Kong, Shatin, NT, Hong Kong, China
第一作者机构：[1]Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China[2]The First Affiliated Hospital of Xinjiang Medical University, Urumqi, China[3]Yulin First People's Hospital, Yulin, China[4]Guilin People's Hospital, Guilin, China[5]The Third Affiliated Hospital of Chongqing Medical University, Chongqing, China[6]OrigiMed, Shanghai, China[7]State Key Laboratory of Translational Oncology, Chinese University of Hong Kong, Shatin, NT, Hong Kong, China
推荐引用方式(GB/T 7714)：
Zhang Baihua,Xia Yu,Zhang Jiujin,et al.Characterization of MET exon 14 skipping in Chinese non-small cell lung cancer (NSCLC) patients.[J].JOURNAL OF CLINICAL ONCOLOGY.2020,38(15):
APA：
Zhang, Baihua,Xia, Yu,Zhang, Jiujin,Yu, Jin,Chen, Min...&Wang, Kai.(2020).Characterization of MET exon 14 skipping in Chinese non-small cell lung cancer (NSCLC) patients..JOURNAL OF CLINICAL ONCOLOGY,38,(15)
MLA：
Zhang, Baihua,et al."Characterization of MET exon 14 skipping in Chinese non-small cell lung cancer (NSCLC) patients.".JOURNAL OF CLINICAL ONCOLOGY 38..15(2020)
医学